instructions): The Administrative Core provides the strategic direction, leadership, organizational structure, communications, oversight and support needed to fulfill the goals of the statewide Arizona Alzheimer's Disease Core Center (ADCC). It promotes the continued development and productive utilization of our Cores and Ancillary Research Programs. It fosters close working relationships among each of our Cores, our Ancillary Research Programs, and Investigators from a wide range of scientific disciplines and institutions in Arizona. It administers our statewide program for the solicitation, competitive review, support and monitoring of ADCC and locally supported pilot studies. It works closely with the National Alzheimer's Coordinating Center (NACC) and the National Institute on Aging (NIA), and supports collaborations with other ADCs and research programs inside and outside Arizona. It receives annual visits, feedback, advice and written reports from our External Advisory Committee. The Administrative Core provides the bridge between our ADCC and our locally supported Arizona Alzheimer's Research Center (AARC), which have complementary, non-overlapping, and mutually supportive roles in the Arizona Alzheimer's Consortium (AAC). Locally, our leaders and their colleagues work closely with the Alzheimer's Association Desert Southwest Chapter, leaders in Arizona's Native American and Latino communities, leading officials from each of our organizations and the state, and our other community partners. Nationally and Internationally, they continue to play important roles In the development of new research initiatives and collaborations, public policies in AD research and care, cognitive aging research, and outreach to some of our most underserved minority communities. They continue to identify, capitalize on, and try to fulfill unique scientific and organizational challenges, and to anticipate and address these unique challenges in association with a statewide, multi-institutional research program. They also continue to capitalize on the organization's particular interests, resources, and strengths in pursuit of their ambitious goals. They continue to secure an extraordinary level of local support, even during this financially challenging time, and they continue to have an extraordinary impact on AD research, care, and services in Arizona.

Public Health Relevance

The Arizona Alzheimer's Disease Center's Administrative Core provides the leadership needed to fulfill the goals of the Center. It continues to develop and use its statewide scientific resources in the most impactful collaborative, and accountable way. It is intended to make potentially transformational differences in the scientific fight against Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG019610-15
Application #
8805815
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
15
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Banner Health
Department
Type
DUNS #
City
Phoenix
State
AZ
Country
United States
Zip Code
85351
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Ren, Yingxue; van Blitterswijk, Marka; Allen, Mariet et al. (2018) TMEM106B haplotypes have distinct gene expression patterns in aged brain. Mol Neurodegener 13:35
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Shaltouki, Atossa; Hsieh, Chung-Han; Kim, Min Joo et al. (2018) Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson's models. Acta Neuropathol 136:607-620
Liu, Xiaonan; Chen, Kewei; Wu, Teresa et al. (2018) Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease. Transl Res 194:56-67
Sekar, Shobana; Cuyugan, Lori; Adkins, Jonathan et al. (2018) Circular RNA expression and regulatory network prediction in posterior cingulate astrocytes in elderly subjects. BMC Genomics 19:340
Kidana, Kiwami; Tatebe, Takuya; Ito, Kaori et al. (2018) Loss of kallikrein-related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice. EMBO Mol Med 10:
Ortuño-Lizarán, Isabel; Beach, Thomas G; Serrano, Geidy E et al. (2018) Phosphorylated ?-synuclein in the retina is a biomarker of Parkinson's disease pathology severity. Mov Disord 33:1315-1324
Limback-Stokin, Martin M; Krell-Roesch, Janina; Roesler, Kimberly et al. (2018) Anticholinergic Medications and Cognitive Function in Late Midlife. Alzheimer Dis Assoc Disord 32:262-264
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021

Showing the most recent 10 out of 794 publications